TOMI Environmental Solutions reports accelerating growth in SteraMist service revenue. Accelerating SteraMist service revenue growth signals stronger core operations and potential market gains for TOMI.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 2.37 | 0.70 | 0.25 | 0.55 |
| Receivables | 2.59 | 1.88 | 0.69 | 1.89 |
| Inventory | 4.63 | 3.58 | 2.93 | 2.81 |
| Other | — | — | — | 0.05 |
| 9.96 | 6.49 | 4.19 | 5.53 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1.27 | 1.92 | 1.48 | 1.60 |
| ST’ Debt | — | — | — | — |
| Other | — | — | 0.25 | — |
| 2.06 | 2.72 | 3.16 | 3.71 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.65 | 2.25 | — | — |
—
|
| ’25 | 1.58 | 1.03 | 2.01 | 1.02 |
5.64
|
| ’24 | 1.11 | 3.01 | 2.54 | 1.07 |
7.74
|
| ’23 | 1.58 | 2.77 | 1.47 | 1.53 |
7.35
|
| ’22 | 2.31 | 1.46 | 1.76 | 2.81 |
8.34
|
| ’21 | 2.07 | 1.47 | 2.20 | 2.01 |
7.75
|
| ’20 | 7.05 | 10.03 | 4.29 | 3.65 |
25.03
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.30 | (1.59) | — | — |
—
|
| ’25 | (0.28) | (0.19) | (0.11) | (0.62) |
(1.20)
|
| ’24 | (1.18) | (0.38) | 0.11 | 0.01 |
(1.44)
|
| ’23 | (1.36) | (0.84) | (0.16) | (1.24) |
(3.60)
|
| ’22 | 0.03 | (0.48) | (0.48) | (0.31) |
(1.23)
|
| ’21 | (1.22) | (1.29) | (1.31) | 0.00 |
(3.82)
|
| ’20 | 3.32 | 2.07 | (0.44) | (0.37) |
4.58
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.29 | (1.61) | — | — |
—
|
| ’25 | (0.28) | (0.25) | (0.18) | (0.62) |
(1.33)
|
| ’24 | (1.27) | (0.38) | 0.10 | (0.14) |
(1.70)
|
| ’23 | (1.40) | (0.90) | (0.16) | (1.36) |
(3.82)
|
| ’22 | 0.01 | (0.53) | (0.49) | (0.47) |
(1.48)
|
| ’21 | (1.25) | (1.46) | (1.41) | (0.35) |
(4.46)
|
| ’20 | 3.30 | 2.04 | (0.45) | (0.72) |
4.18
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.12) | (0.05) | — | — |
—
|
| ’25 | (0.03) | (0.18) | (0.06) | (0.27) |
(0.57)
|
| ’24 | (0.21) | 0.00 | 0.00 | (0.48) |
(0.66)
|
| ’23 | (0.18) | 0.00 | (0.15) | (0.18) |
(0.51)
|
| ’22 | (0.09) | (0.12) | (0.09) | (0.12) |
(0.45)
|
| ’21 | (0.27) | (0.15) | (0.09) | (0.24) |
(0.75)
|
| ’20 | 0.14 | 0.20 | 0.15 | (0.51) |
0.69
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 1.35 | 1.38 | 1.56 | 1.89 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 5.22 | 4.17 | 3.48 | 4.50 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 30 | 26 | 20 | 20 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.28 | 0.28 | 0.39 | 0.28 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.34 | 7.35 | 7.74 | 5.64 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 60.69% | 58.32% | 45.96% | 54.60% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.88) | (3.40) | (4.48) | (3.75) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (34.54%) | (46.26%) | (57.85%) | (66.52%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.88) | (3.40) | (4.48) | (3.75) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.50 | 0.53 | 0.52 | 0.50 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.27 | 1.11 | 1.16 | 0.84 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.45) | (0.51) | (0.66) | (0.57) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.19) | (0.54) | (0.22) | (0.18) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.04) | (0.03) | (0.04) | (0.02) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.22) | (0.58) | (0.26) | (0.20) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.74 | 1.26 | 0.62 | 0.09 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.58 | 6.61 | 6.66 | 6.69 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.30 | 2.78 | 2.71 | 2.78 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.95 | 2.44 | 5.12 | 26.63 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.89 | 2.78 | 2.94 | 3.27 | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.02) | (5.37) | (13.38) | (12.38) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.23) | (3.60) | (1.44) | (1.20) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.24) | (0.22) | (0.26) | (0.14) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.48) | (3.82) | (1.70) | (1.33) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.84 | 7.90 | 3.77 | 1.02 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.86 | 2.30 | 2.36 | 2.91 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.45) | (0.07) | 1.66 | 2.66 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.45 | 8.36 | 4.10 | 0.59 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (18.13%) | (23.58%) | (38.84%) | (44.82%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (22.53%) | (25.26%) | (44.55%) | (74.09%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (23.00%) | (34.36%) | (71.88%) | (160.00%) | — | — | — |
ROE
|
TOMI Environmental Solutions (TOMZ) rode the COVID wave to explosive growth in 2020, with revenues skyrocketing 294% to $25 million and flipping to profitability on surging demand for its EPA-registered SteraMist antimicrobial tech—proving the disruptive power of its binary ionization platform in crisis-driven markets. Post-pandemic normalization slashed sales back to $7-8 million, but analysts forecast a thrilling rebound: down slightly to $6.93 million in 2024, then surging 69% to $11.69 million in 2025 and another 57% to $18.37 million in 2026, potentially recapturing pandemic peaks amid rising hygiene needs in hospitals and industry.
Valuations scream opportunity today, with PS ratios at historical lows of 2.7x and forward multiples dipping to 0.77x by 2026, implying massive asymmetry for growth speculators—analyst targets point to 400% upside from current levels, backed by tight consensus and echoes of 2020’s undervalued entry. Despite persistent losses, resilient gross margins (46-62% historically) and modest debt set the stage for operational leverage if revenue triples cumulatively, with Monte Carlo odds at 35-55% for hitting targets.
This high-beta microcap embodies speculative upside in emerging disinfection innovation, poised for tailwinds like biodefense contracts and infrastructure hygiene demands—perfect for portfolios chasing 150% risk-adjusted returns. Dive into the full analysis for the data-driven models and execution catalysts.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.